Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The Protective Mechanisms GLP-1 receptor agonists reduce hepatic steatosis (fat accumulation in liver cells), decrease inflammation markers, and improve insulin sensitivity at the liver level
Larger individuals or those engaging in significant physical activity may need more
What payers require for Zepbound prior authorization Zepbound PA requirements are typically more stringent: Documented BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity Evidence of lifestyle intervention including documented participation in diet, exercise, and behavioral modification programs (usually for at least 3 to 6 months) Prior medication trials (some plans require documented failure of other weight management medications before approving tirzepatide) Specialist involvement (some plans require referral to or management by a bariatric medicine specialist, endocrinologist, or obesity medicine physician) Ongoing weight monitoring documentation with specific weight loss targets (typically 5% of baseline weight within 3 to 6 months of starting therapy) Patients researching BMI requirements for GLP-1 medications should understand that these thresholds directly correspond to the prior authorization criteria their provider must document
understanding what's in your supplements and how they interact is always smart
Small food still counts
What makes this particularly brilliant is how it targets hyperpigmentation at the source
